Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers

Psychiatry Research

Volumn 79, Issue 1, 1998, Pages 1-9

  Jönsson, Erik G ^a   Nöthen, Markus M ^b   Gustavsson, J Petter ^a   Neidt, Helge ^b   Bunzel, Roland ^b   Propping, Peter ^b   Sedvall, Göran C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Cerebrospinal fluid; Dopamine transporter gene; Monoamine metabolites (HVA, 5 HIAA, MHPG); Norepinephrine transporter gene; Serotonin transporter gene

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE TRANSPORTER; HOMOVANILLIC ACID; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONCENTRATION RESPONSE; DRUG METABOLISM; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MONOAMINE METABOLISM; NORADRENALIN RELEASE; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; ANALYSIS OF VARIANCE; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; CARRIER PROTEINS; COHORT STUDIES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENOTYPE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX FACTORS; SYMPORTERS;

EID: 0038179022     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(98)00027-4     Document Type: Article

References (37)

1. Ågren H., Meffords I., Rudorfer M., Linnoila M., Potter W. Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF. Journal of Psychiatric Research. 20:1986;175-193.
2. American Psychiatric Association, 1987. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed revised. American Psychiatric Association, Washington, DC.
3. Aston-Jones G., Ennis M., Pierebone W.A., Nickell W.T., Shipley M.T. The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. Science. 234:1986;734-737.
4. Battersby S., Ogilvie A.D., Smith C.A.D., Blackwood D.H.R., Muir W.J., Quinn J.P., Fink G., Goodwin G.M., Harmar A.J. Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder. Psychiatric Genetics. 6:1996;177-181.
5. Best N.R., Rees M.P., Barlow D.H., Cowen P.J. Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology. 17:1992;87-93.
6. Blennow K., Wallin A., Gottfries C.G., Karlsson I., Månsson J.E., Skoog I., Wikkelsö C., Svennerholm L. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals. European Neuropsychopharmacology. 3:1993;55-61.
7. Brüss M., Kunz J., Lingen B., Bönisch H. Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter. Human Genetics. 91:1993;278-280.
8. Cederbaum J.M., Aghajanian G.K. Afferent projections to the rat nucleus coeruleus as determined by a retrograde technique. Journal of Comparative Neurology. 178:1978;1-16.
9. Cohen, J., Cohen, P., 1983. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, 2nd ed. Lawrence Erlbaum Associated, Hillsdale, New Jersey.
10. Constantino J.N., Murphy D.L. Monoamine metabolites in 'leftover' newborn human cerebrospinal fluid. A potential resource for biobehavioral research. Psychiatry Research. 65:1996;129-142.
11. Geijer T., Neiman J., Rydberg U., Gyllander A., Jönsson E., Sedvall G., Valverius P., Terenius L. Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics. European Archives of Psychiatry and Clinical Neuroscience. 244:1994;26-32.
12. Gelernter J., Kruger S., Pakstis A.J., Pacholczyk T., Sparkes R.S., Kidd K.K., Amara S.G. Assignment of the norepinephrine transporter protein (NET 1) locus to chromosome 16. Genomics. 18:1993;690-692.
13. Gelernter J., Pakstis A.J., Kidd K.K. Linkage mapping of serotonin transporter protein gene SLC6A4 on chromosome 17. Human Genetics. 95:1995;677-680.
14. Grove W.M., Andreasen N. Simultaneous tests of many hypotheses in exploratory research. Journal of Nervous and Mental Disease. 170:1982;3-8.
15. Heils A., Teufel A., Petri S., Stöber G., Riederer P., Bengel D., Lesch K.P. Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry. 66:1996;2621-2624.
16. Higley J.D., Thompson W.W., Champoux M., Goldman D., Hasert M.F., Kraemer G.W., Scanlan J.M., Suomi S.J., Linnoila M. Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta). Archives of General Psychiatry. 50:1993;615-623.
17. Hsiao J.K., Potter W.Z., Ågren H., Owen R.R., Pickar D. Clinical investigation of monoamine neurotransmitter interactions. Psychopharmacology. 112:1993;S76-S84.
18. Jönsson E., Sedvall G., Brené S., Gustavsson J.P., Geijer T., Terenius L., Crocq M.-A., Lannfelt L., Tylec A., Sokoloff P., Schwartz J.C., Wiesel F.-A. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biological Psychiatry. 40:1996;1032-1043.
19. Jönsson E.G., Goldman D., Spurlock G., Gustavsson J.P., Nielsen D.A., Linnoila M., Owen M.J., Sedvall G.C. Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms. Relationships to monoamine metabolite concentrations in CSF of healthy volunteers. European Archives of Psychiatry and Clinical Neuroscience. 247:1997;297-302.
20. Kitayama S., Dohi T. Cellular and molecular aspects of monoamine neurotransmitter transporters. Japanese Journal of Pharmacology. 72:1996;195-208.
21. Leger L., Descarries L. Serotonin nerve terminals in the locus coeruleus of adult rat: a radioautographic study. Brain Research. 145:1978;1-13.
22. Lesch K.-P., Balling U., Gross J., Strauss K., Wolozin B., Murphy D., Riederer P. Organization of the human serotonin transporter gene. Journal of Neural Transmission. 95:1994;157-162.
23. Lesch K.-P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Müller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1996;1527-1531.
24. Mongeau R., Blier P., de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Research and Brain Research Reviews. 23:1997;145-195.
25. Nordin C., Eklundh T., Fernström V., Swedin A., Zachau A.C. Gradients of CSF monoamine metabolites: a comparison between male and female volunteers. Journal of Psychiatry Research. 29:1995;133-140.
26. Ogilvie A.G., Battersby S., Bubb V.J., Fink G., Harmar A.J., Goodwin G.M., Smith C.A.D. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet. 347:1996;731-733.
27. Oxenstierna G., Edman G., Iselius L., Oreland L., Ross S.B., Sedvall G. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals - a genetic study. Journal of Psychiatric Research. 20:1986;19-29.
28. Pickel V.M., Toh J.H., Reis D.J. A serotonergic innervation of noradrenergic neurons in nucleus locus coeruleus: demonstration by immunocytochemical localization of the transmitter specific enzymes tyrosine and tryptophan hydroxylase. Brain Research. 131:1977;197-214.
29. Potter W.Z., Manji H.K. Catecholamines in depression: an update. Clinical Chemistry. 40:1994;279-287.
30. Ramamoorthy S., Baumann A., Moore K., Han H., Yang-Feng T., Chang A., Ganapathy V., Blakely R. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression and chromosomal localization. Proceedings of the National Academy of Sciences of the United States of America. 90:1993;2542-2546.
31. Sedvall G., Fyrö B., Gullberg B., Nybäck H., Wiesel F.-A., Wode-Helgodt B. Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. British Journal of Psychiatry. 136:1980;366-374.
32. Segal M. Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli. Journal of Physiology. 286:1979;401-405.
33. Stöber G., Nöthen M.M., Pörzgen P., Brüss M., Bönisch H., Knapp M., Beckmann H., Propping P. Systemic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. American Journal of Medical Genetics. 67:1996;523-532.
34. Swahn C.-G., Sandgärde B., Wiesel F.-A., Sedvall G. Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method. Psychopharmacology. 48:1976;147-152.
35. van Kammen D.P., Antelman S. Impaired noradrenergic transmission in schizophrenia? Life Sciences. 34:1984;1403-1413.
36. Vandenbergh D.J., Persico A.M., Hawkins A.L., Griffin C.A., Li X., Jabs E.W., Uhl G.R. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics. 14:1992;1104-1106.
37. Woolley D.W., Shaw E. A biochemical and pharmacological suggestion about certain mental disorders. Proceedings of the National Academy of Sciences of the United States of America. 40:1954;228-231.